{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:47:09Z","timestamp":1785527229014,"version":"3.56.0"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10549-026-08016-1","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:48:28Z","timestamp":1782474508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comments on: Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer"],"prefix":"10.1007","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-5630","authenticated-orcid":false,"given":"Rajesh Prasad","family":"Jayaswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2167-928X","authenticated-orcid":false,"given":"Anuj Kumar","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7715-664X","authenticated-orcid":false,"given":"Rama Kumari","family":"Badyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"8016_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10549-026-07948-y","volume":"217","author":"T Chiddarwar","year":"2026","unstructured":"Chiddarwar T, Blaes A, Kuntz K (2026) Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer. Breast Cancer Res Treat 217:2. https:\/\/doi.org\/10.1007\/s10549-026-07948-y","journal-title":"Breast Cancer Res Treat"},{"key":"8016_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/ph18050727","volume":"18","author":"S Otero-Torres","year":"2025","unstructured":"Otero-Torres S, Rodr\u00edguez-Mauriz R, Fort-Casamartina E, Clop\u00e9s-Estela A, Soler-Rotllant F, Fontanals-Mart\u00ednez S et al (2025) DPYD genotyping, fluoropyrimidine dosage and toxicity: an umbrella review of systematic reviews. Pharmaceuticals 18:727. https:\/\/doi.org\/10.3390\/ph18050727","journal-title":"Pharmaceuticals"},{"key":"8016_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/pme-2022-0133","volume":"20","author":"R Koleva-Kolarova","year":"2023","unstructured":"Koleva-Kolarova R, Vellekoop H, Huygens S, Versteegh M, van Molken M, Szilberhorn L et al (2023) Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems. Personalized Med 20:357\u2013374. https:\/\/doi.org\/10.2217\/pme-2022-0133","journal-title":"Personalized Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08016-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:10:20Z","timestamp":1785521420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-08016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":3,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8016"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08016-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is a correspondence\/commentary and does not involve human participants, animals, or identifiable patient data.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"65"}}